Petros Pharmaceuticals, Inc.
PTPI· OTC
PTPIPetros Pharmaceuticals, Inc.
Filed Nov 15, 2021 · 10-Q · 46 days after period end · 0001104659-21-139299
| Metric | Q3 2021 | Q3 2020 |
|---|---|---|
| Revenue | $2.15M | $3.46M |
| Net Income | -$1.70M | -$3.30M |
| EPS Diluted | -$0.17 | -$0.96 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petros Pharmaceuticals, Inc. · CIK 1815903 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 15, 2021 · 46 d after period end
